Product Overview
Ralimetinib dimesylate | T6047 | TargetMol Chemicals
CAS: 862507-23-1
Smiles: CS(O)(=O)=O.CS(O)(=O)=O.CC(C)(C)Cn1c(N)nc2ccc(nc12)-c1[nH]c(nc1-c1ccc(F)cc1)C(C)(C)C
Formula: C26H37FN6O6S2
Pathway: Apoptosis|||Autophagy|||MAPK
Target: Apoptosis|||p38 MAPK|||Autophagy
Receptor: N/A
Bioactivity: Ralimetinib Mesylate is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.
Molecular Weight: 612, 74
